Muscles weaken, speech slurs and breathing becomes difficult in ALS. It’s often viewed as a steady decline, but the reality is more complex and varies for each individual. Some people live only months ...

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in ...

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in ...

The health regulator has requested an update to technical information on the drug, Spinraza, to be included in the Chemistry ...

The FDA letter requested that a technical information update be included in the Chemistry Manufacturing and Controls (CMC) ...

The FDA re-approved Wellcovorin, a drug from GSK, that the company stopped selling more than 25 years ago, as part of a push from the Trump administration to identify the causes of and potential ...

The complete response letter was issued by the FDA during a routine inspection of a third-party fill-finish facility, not because of an issue with apitegromab.

Ten-year-old Sebastian Veiman is racing against time to receive €2.5 million gene therapy that could halt — or even reverse — ...

Scholar Rock Holding said the Food and Drug Administration has turned away its application seeking approval of apitegromab for the rare genetic neuromuscular disease spinal muscular atrophy due to ...

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents ...

Nathanael was 11 months old when he was diagnosed - now his family hopes screening will spare others the same wait.